- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Racial and Ethnic Disparities in Prior Authorizations for Patients With CancerThe prior authorization process for patients with cancer demonstrates fewer days until submission and lower denial rates for Asian patients relative to White patients.
Latest:
Small Practice Participation and Performance in Medicare Accountable Care OrganizationsMedicare beneficiaries attributed to small practices in accountable care organizations (ACOs) achieve greater savings than beneficiaries attributed to large practices in ACOs.
Latest:
Evaluating Smoking Cessation Service at an Emergency Department Clinical Observation UnitThis study aimed to evaluate the impact of a smoking cessation service in a group of patients admitted to a short-stay unit in the emergency department.
Latest:
Actions to Improve Quality: Results From a National Hospital SurveyHospitals reported widespread adoption of quality improvement (QI) changes to improve on CMS quality measures, and QI adoption was associated with improved performance on quality measures.
Latest:
Eliminating Defects in Value: Turnaround of an MSSP ACOA health system transformational leadership framework and management system made visible and eliminated defects in value and was associated with reduced annual Medicare expenditures and increased quality between 2017 and 2020.
Latest:
Twice-Daily ESK-001 Treatment Shows Majority of Psoriasis Patients Achieve PASI 75These 28-week data on twice-daily ESK-001 highlight the drug’s safety and efficacy among patients with psoriasis.
Latest:
Inability to Access Health Care Due to COVID-19 Among Medicare BeneficiariesUp to one-fifth of Medicare beneficiaries were unable to access health care due to the COVID-19 pandemic in 2020.
Latest:
Medicare Advantage–Pharmacy Partnership Improves Influenza and Pneumococcal Vaccination RatesPatients whose pharmacy receives notification of their immunization gap have twice the odds of receiving immunizations compared with those whose pharmacy does not receive the notification.
Latest:
Safety vs Price in the Generic Drug Market: MetforminThe generic drug market focuses on price. However, multiple generic metformin drugs have been recalled due to poor drug quality. The authors examine price and quality after these recalls.
Latest:
Consumer-Centric Approach to Enhance Access to Pediatric Specialty CareThe authors’ organization optimized scheduling techniques that improved patient access to pediatric specialists to within 7 calendar days for new patients.
Latest:
The Relationship Between the Follow-up to Discharge Ratio and Length of StayThe objective was to evaluate the correlation between the follow-up to discharge ratio and average length of stay.
Latest:
Clinical Profile of COVID-19 Infection in Postvaccination IndividualsThis article describes the findings of an observational study carried out in India to examine the clinical profile of individuals detected to be COVID-19 positive post vaccination.
Latest:
Machine Intelligence for Early Targeted Precision Management and Response to Outbreaks of Respiratory InfectionsThis paper evaluates novel machine intelligence to predict patients at risk of severe respiratory infections and recommend postacute care providers likely to reduce infection risk.
Latest:
The Accelerated Approval Program for Oncology Drugs: Celebrating More Than 250,000 Life-Years Gained and CountingThis commentary explores how 2 recently published studies evaluating the clinical benefit of the FDA’s accelerated approval program for oncology drugs came to different conclusions.
Latest:
A 10-Step Program to Successfully Reduce Low-Value CareThe frequency of low-value care can be reduced by a respectful, data-driven process anchored in nonjudgmental communication and explicit core values.
Latest:
Cost-Benefit Analysis of Sacubitril/Valsartan in a Medicaid PopulationThe cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan.
Latest:
Primary Care Referrals to Nephrology in Patients With Advanced Kidney DiseasePrimary care physicians did not refer the majority of patients with severe nephropathy to specialists; nonreferred patients had fewer comorbidities and might be better kidney transplant candidates.
Latest:
Evaluating Proactive Outreach for Prior Authorization Recertifications in Medicaid PatientsImplementing a proactive provider outreach program resulted in significantly more prior authorization recertifications and a reduction in time to submission.
Latest:
Primary Care Transformation: A Team-Based Care ModelThis article presents a descriptive review of a team-based care transformation model in a large primary care network, including core staffing, process improvement, and extended care teams.
Latest:
Influence of Prior Authorization Requirements on Provider Clinical Decision-MakingAn online survey identified that documentation requirements and communication issues with health plans are associated with providers modifying clinical decisions to avoid medication prior authorization.
Latest:
Cost Savings Associated With Electronic Specialty ConsultationsThis retrospective cohort evaluation found that patients receiving electronic, compared with face-to-face, specialty consultation had significantly lower health care costs for at least 3 months.
Latest:
Therapists’ Perspectives on Access to Telemental Health Among Medicaid-Enrolled YouthThis qualitative study elucidates therapists’ perspectives on barriers to and facilitators of access to telemental health among Medicaid-enrolled youth served by a large safety-net organization.
Latest:
Influence of Health Care Systems on Mortality in Adult Patients With CancerVertically integrated health care delivery systems may be well positioned to help reduce overall mortality and specifically mitigate racial/ethnic disparity gaps in cancer care outcomes.
Latest:
Expert Perspectives on the Role of Real-World Evidence, Patient-Reported Outcomes, and Economic Models in Oncology Formulary Decision and Regulatory Submissions for FDA ApprovalA Q&A With Bhakti Arondekar, PhD, MBA; Alexander Niyazov, PharmD, MPH; and Jay Weaver, PharmD, MPH
Latest:
Contributor: The Digital Shift—Meeting Modern Patient ExpectationsAn analysis of patient preferences in provider search and scheduling
Latest:
Differences in Spending for Diabetes and Multiple Chronic Conditions in Michigan Medicare BeneficiariesDiabetes and multiple chronic conditions increase overall Medicare spending, but spending increases even more in minority beneficiaries compared with White beneficiaries with similar comorbidity combinations.
Latest:
Future Directions of BTK Inhibitors in Leukemia and LymphomaExperts discuss future directions of BTK inhibitors.
